SUMMARY Daily measurements of finger joint size, grip strength, and body weight have been made throughout 2 complete menstrual cycles in 7 female patients with rheumatoid arthritis and 6 healthy female controls. Sine wave analysis showed significant individual cyclical rhythms (p<OO5) for finger joint size (5 patients, 4 controls), nude weight (5 patients, 3 controls), and grip strength (4 patients, 3 controls). In addition analysis of group data, on the assumption of a 28-day cycle, showed a significant cycle for grip strength in the rheumatoid patients, with a nadir at 28 days. In the normal subjects much of the cyclical variation in finger joint size could be explained by changes in weight (median 49-5 %), but this was not so in patients with rheumatoid arthritis (median 2 8 %). These findings suggest the existence of a cyclical variation in disease activity in rheumatoid arthritis.
We have noted that a number of young women with rheumatoid arthritis (RA) complain of an exacerbation of symptoms just before or at the time of menstruation. Such 
Results

INDIVIDUAL ANALYSIS
Individual cycle lengths for the observed cycles in the 13 subjects varied from 21 to 35 days. Table 1 shows the means and variation of FJS, body weight, and grip strength occurring in the rheumatoid and control subjects together with the timing of the peaks. Table 2 shows by means of computerised sine wave analysis that of the 7 patients with RA 6 showed significant cycles for body weight (p<O 05), 4 for FJS (p<O O1), and 4 for grip strength (p<005). The corresponding data for the 6 control subjects show 4, 3, and 2 significant cycles respectively.
Figure la is a graphical representation of the daily measurements recorded by one patient with RA over the course of 2 menstrual cycles. Weight and FJS increased and grip strength decreased at menstruation. This pattern was repeated during the second cycle. Figure lb shows the same data with a sine wave corresponding to the patient's own cycle length (28 days) superimposed. Computerised sine wave analysis showed the weight and grip strength cycles to be significant (p<O0OO1 and p<O-05 respectively).
GROUP ANALYSIS
Analysing the patients with RA and controls in separate groups and assuming a 28-day cycle we obtained a significant, rhythm for grip strength in the patients with RA (p<0 05) with a peak at 14-3 days (Fig. 2 ). *Subject showed a significant correlation (p<002) between finger joint size and weight. (Table 3) We have previously described a linear correlation between FJS and change in body weight. 4 In this study 3 of the 7 patients with RA and 5 of 6 controls showed such a correlation (p<O0 02 for each). Most of the patients and controls showed a significant cycle of body weight, with the maximum occurring around the time of menstruation-a finding previously described in normal subjects.6 A significant cyclical change in FJS was seen in 4 of 7 patients with RA, with all peaks occurring within 6 days of the start of menstruation. It is interesting to note that, even in the nonsignificant cycles in rheumatoid patients, peak FJS was recorded around the time of menstruation. Significant cycles for grip strength were obtained in 4 of 7 patients with RA, and in 6 of the 7 patients studied the peak occurred at mid cycle. This closely corresponds with the results of group analysis of rheumatoid patients, in whom a significant cycle for grip strength was observed with a peak at 14-3 days. Thus we have demonstrated menstrual cyclicity in both FJS and grip strength and have shown that peak values for these parameters occur at menstruation and mid cycle respectively, suggesting an inverse relationship. To our knowledge such menstrual cyclicity has not been previously reported.
The reproducibility of grip strength and FJS measurements has been well demonstrated provided they are undertaken by the same individual at the same time of day.9 10 Recent work from our unit has confirmed that such measurements can be successfully undertaken by patients in their own homes." This and another recent study"2 have confirmed the marked circadian variations in both these parameters. In retrospect it is therefore possible that by allowing our subjects a period of up to 3 hours in which to make measurements we may have obscured some menstrual or other variations.
Our method of statistical analysis will also tend to underestimate the amplitude of any cyclical variation where this is not of sine wave form, for example, hormonal concentrations (Fig. 3) .13 In addition there are clear problems of fitting sine waves to cycles of varying lengths where one part of the cycle (the luteal phase) remains almost constant at 14 days. The further the actual cycle length varies from 28 days, the less well will a sine curve fit. In view of this we have also presented the raw data in Table 1 23 it is questionable whether either plays an important role in vivo. It should also be remembered that the levels of both hormones are much higher in preg- nancy and that oestrogen is largely in the form of oestriol rather than oestradiol. Some of the various pregnancy-associated proteins also implicated in the pregnancy remission experienced by many women with RA are also present at a low level in the nonpregnant state, but so far studies have not revealed any significant menstrual cyclicity. 24 Our results demonstrate the existence of a menstrual cyclicity in objective signs of RA and strongly suggest that this relates to variations in disease activity. They thereby introduce a further variable which requires consideration whenever disease activity in females is assessed. This applies particularly to clinical drug trials, which commonly involve young women but rarely employ observation periods in multiples of 4 weeks. While the underlying mechanism for these fluctuations remains unknown, it is of great value for the patient to be aware of such endogenous variations in disease activity, since it may allow her management to be modified accordingly. 
